Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F

The Global Blood Transfusion Devices Market is projected to grow from USD 4.97 Billion in 2025 to USD 6.97 Billion by 2031 at a 5.8% CAGR. These specialized medical tools, which include access catheters, tubing, and filters, are engineered to enable the secure and regulated intravenous delivery of blood and its components from donors to patients. Market growth is largely fueled by the rising worldwide frequency of trauma incidents, surgeries, and chronic illnesses that rely on transfusions. Additionally, the growing rates of health issues requiring repeated blood transfusions, like kidney disease, cancer, and anemia, play a major role in driving the industry forward. Notably, an abstract from the AABB 2025 Annual Meeting highlighted that overall institutional transfusions of packed red blood cells in 2024 maintained a decrease of roughly 15-23% against the 2019 baseline of 11,850 units.

A major hurdle hindering the growth of this market is the high operational and capital expenditure tied to sophisticated transfusion technologies. Such hefty costs often act as a financial obstacle to the implementation of these devices, especially in low- and middle-income nations, consequently restricting global access to state-of-the-art transfusion treatments.

Market Driver

A major factor propelling the need for blood transfusion equipment is the rising number of surgical operations, given that many lengthy and complex medical interventions depend on transfusions to control bleeding and keep patients stable. Improved surgical methods and broader healthcare accessibility have led to a consistent global increase in the number of surgeries performed. Highlighting this trend, a November 2025 systematic review in PMC projected that by 2050, Total Hip Arthroplasty (THA) procedures could surge by 121% to over 200%, while Total Knee Arthroplasty (TKA) operations are anticipated to grow by a minimum of 130% internationally, emphasizing the ongoing expansion of treatments that regularly require blood support.

Additionally, the escalating rates of chronic illnesses and blood disorders serve as a core catalyst for the expansion of the blood transfusion devices industry. Illnesses like sickle cell disease, severe anemia, thalassemias, and specific types of cancer often depend on periodic or routine blood transfusions for effective patient care. The Global footprint of these health issues is immense, with the World Health Organization's 2025 anemia report indicating that 30.7% of women between 15 and 49 years old experienced anemia in 2023. This ongoing requirement for blood directly accelerates the need for highly effective transfusion tools, even as the American Red Cross reported a 35% drop in the national blood supply in January 2026 compared to the previous month, underscoring severe constraints on the availability of transfusable blood.

Market Challenge

The heavy financial burden regarding both capital and operational expenses for cutting-edge transfusion technologies poses a major obstacle to the expansion of the Global Blood Transfusion Devices Market. These steep costs create fiscal roadblocks for medical facilities, disproportionately lowering adoption rates in low- and middle-income nations. The steep upfront costs needed to procure advanced machinery, combined with continuous maintenance and running fees, severely restrict the capacity of numerous healthcare institutions to purchase or upgrade to contemporary transfusion systems.

Such economic pressures directly slow down market growth by limiting buyers' financial flexibility and postponing the adoption of new technologies. Highlighting this issue, an abstract from the AABB 2025 Annual Meeting revealed that a hospital system's overall expenditure on blood products surged by 19.8%, climbing from $12.8 million in 2020 to $15.3 million in 2024. The escalating operational costs associated with acquiring blood products subsequently shrink the funds available for investing in updated blood transfusion equipment, ultimately hindering market reach and the global deployment of advanced medical systems.

Market Trends

The rising integration of automation within blood collection and processing equipment is a central industry trend, serving to boost productivity and reduce human error during blood product preparation. This shift significantly impacts the sector by generating demand for sophisticated, automated technologies that optimize laboratory operations and increase the precision of sample management. Demonstrating this benefit, an abstract from the AABB 2025 Annual Meeting detailed how a major academic and research hospital saved roughly two hours of a technologist's time per cycle during red blood cell antigen testing by utilizing an automated immunohematology analyzer. These improvements in efficiency are essential for transfusion centers and blood banks needing to process growing quantities of blood products rapidly and reliably.

At the same time, the rising adoption of point-of-care and home-based transfusion equipment highlights a major evolution in medical care, bringing blood administration directly into the patient's immediate environment rather than relying solely on conventional clinical facilities. This movement broadens the reach of transfusion treatments, especially for individuals who need rapid or recurring care. As a result, the industry is seeing a surge in requests for intuitive, portable instruments that can securely and efficiently deliver blood components across various non-hospital environments. Supporting this shift, America's Blood Centers reported in February 2026 that new national statistics on prehospital transfusions confirm these critical interventions are frequently taking place before patients arrive at medical centers, underscoring the expanding role of transfusion equipment in home care and emergency situations.

Key Market Players

• Immucor Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Terumo Corporation
• Grifols SA
• Kaneka Corporation
• Fresenius Kabi AG
• Haemonetics Corporation
• Macopharma SA
• Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product

• Apheresis Systems
• Infusion Devices
• Blood Warmers
• Venous Access Devices
• Filters
• Others

Blood Transfusion Devices Market, By End Use

• Hospital
• Ambulatory Surgical Centers
• Dialysis Centers
• Blood Bank
• Others

Blood Transfusion Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations:

Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).